Omnicell Inc (OMCL)
27.93
+0.80
(+2.95%)
USD |
NASDAQ |
Apr 26, 16:00
27.93
0.00 (0.00%)
After-Hours: 20:00
Omnicell SG&A Expense (Quarterly): 101.95M for Dec. 31, 2023
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 101.95M |
September 30, 2023 | 103.97M |
June 30, 2023 | 103.56M |
March 31, 2023 | 125.11M |
December 31, 2022 | 131.70M |
September 30, 2022 | 115.46M |
June 30, 2022 | 119.25M |
March 31, 2022 | 119.93M |
December 31, 2021 | 115.76M |
September 30, 2021 | 97.91M |
June 30, 2021 | 89.17M |
March 31, 2021 | 86.59M |
December 31, 2020 | 87.96M |
September 30, 2020 | 71.44M |
June 30, 2020 | 69.39M |
March 31, 2020 | 78.82M |
December 31, 2019 | 82.33M |
September 30, 2019 | 70.88M |
June 30, 2019 | 68.43M |
March 31, 2019 | 68.28M |
December 31, 2018 | 66.26M |
September 30, 2018 | 65.61M |
June 30, 2018 | 65.94M |
March 31, 2018 | 65.28M |
December 31, 2017 | 61.40M |
Date | Value |
---|---|
September 30, 2017 | 56.21M |
June 30, 2017 | 61.92M |
March 31, 2017 | 61.94M |
December 31, 2016 | 47.97M |
September 30, 2016 | 61.32M |
June 30, 2016 | 64.34M |
March 31, 2016 | 64.26M |
December 31, 2015 | 43.89M |
September 30, 2015 | 40.67M |
June 30, 2015 | 39.74M |
March 31, 2015 | 43.29M |
December 31, 2014 | 42.17M |
September 30, 2014 | 38.87M |
June 30, 2014 | 37.01M |
March 31, 2014 | 38.42M |
December 31, 2013 | 38.13M |
September 30, 2013 | 34.76M |
June 30, 2013 | 32.86M |
March 31, 2013 | 33.24M |
December 31, 2012 | 33.35M |
September 30, 2012 | 29.32M |
June 30, 2012 | 31.45M |
March 31, 2012 | 25.62M |
December 31, 2011 | 23.81M |
September 30, 2011 | 23.64M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
68.43M
Minimum
Jun 2019
131.70M
Maximum
Dec 2022
96.82M
Average
97.91M
Median
Sep 2021
SG&A Expense (Quarterly) Benchmarks
Teladoc Health Inc | 309.56M |
American Shared Hospital Services | 1.76M |
Novo Integrated Sciences Inc | 2.864M |
Astrana Health Inc | 37.95M |
Cryo-Cell International Inc | 4.340M |